Unknown HPLC or UPLC peak
Collect a target peak that cannot be identified adequately in the original analytical mixture.
Isolate the unknown before definitive structure confirmation
Low-level impurities can be visible in an analytical chromatogram but still be too dilute or too complex for definitive structural work. Triclinic Labs develops a fit-for-purpose preparative liquid chromatography (LC) workflow to separate the target from the active pharmaceutical ingredient, degradants, excipients, and other matrix components.
The isolated fraction can then be assessed by liquid chromatography-high-resolution mass spectrometry (LC-HRMS), tandem mass spectrometry (MS/MS), nuclear magnetic resonance (NMR), or another orthogonal technique. The project scope depends on the available sample, chromatographic selectivity, impurity level, stability, and the evidence needed for the development or quality decision.
Planning principle: Isolation is a means to obtain decision-quality evidence. The target amount, purity, and analytical sequence must be defined around the required structural conclusion.
Impurity-isolation problems our scientists can addresses:
Process impurity
Separate a synthesis byproduct, intermediate, reagent-derived product, or other process-related unknown.
Degradation product
Isolate a component generated by heat, light, oxidation, hydrolysis, moisture, pH, or formulation conditions.
Drug-product impurity
Resolve an unknown associated with an API-excipient interaction, packaging, storage, or manufacturing.
Coelution or mixture complexity
Adapt the separation when matrix components interfere with mass-spectrometric or spectroscopic interpretation.
Purified fraction for confirmation
Prepare material for NMR, reference comparison, additional characterization, or another agreed confirmatory step.
Integrated isolation and identification workflow we suggest:
- Review existing data
Evaluate the analytical method, chromatogram, sample history, and decision. - Assess feasibility
Consider selectivity, impurity level, sample quantity, stability, and detection. - Adapt the separation
Develop a fit-for-purpose preparative LC approach. - Collect fractions
Track and collect the target while limiting cross-contamination. - Pool and concentrate
Combine suitable fractions and prepare them for characterization. - Check purity and identity
Confirm that the isolated fraction contains the intended target. - Apply LC-MS or NMR
Generate the structural evidence required by the project. - Report conclusions
State the result, evidence, limitations, and next decision.
Information we use for developing a design of experiment:
| Project input | Why it matters |
|---|---|
| Analytical method and representative chromatogram | Shows retention, resolution, peak shape, run time, and potential collection windows. |
| Detection wavelength and available mass-spectrometric data | Helps track the target and distinguish it from coeluting components. |
| Sample concentration and available mass or volume | Sets realistic expectations for the amount of isolated material. |
| Mobile phase, buffer, pH, and solvent composition | Determines compatibility with scale-up, concentration, and downstream analysis. |
| Sample and impurity stability | Identifies handling, temperature, light, time, or pH controls that may be required. |
| Desired isolated amount, purity, and intended analysis | Defines whether the separation is adequate for LC-MS, NMR, comparison, or another use. |
When direct LC-MS is enough, and when chromatographic isolation adds value:
| Analytical situation | Likely next step | Reason |
|---|---|---|
| A resolved low-level peak produces interpretable accurate-mass and MS/MS data | Begin with direct LC-HRMS/MS | Mass and fragmentation evidence may support a tentative or probable assignment without isolation. |
| Coelution, ion suppression, or a complex mixture prevents interpretation | Isolate or enrich the target | Separation can reduce interference and improve the quality of downstream data. |
| Connectivity, stereochemical detail, or definitive confirmation is required | Isolate enough sufficiently pure material for NMR or another confirmatory method | NMR and some orthogonal methods require a purified, concentrated sample. |
| A purified fraction or reference material is needed for comparison | Define a collection and characterization plan | The required amount, purity, stability, and intended use must guide the isolation strategy. |
Typical project deliverables and practical limits
- Feasibility assessment based on the available analytical method, chromatogram, and sample.
- Documented approach for preparative separation and fraction-collection.
- Purity or composition assessment of the selected fraction.
- LC-HRMS, MS/MS, NMR, or other agreed characterization results.
- Integrated interpretation with stated confidence and limitations.
- Recommendations for additional confirmation when the available material does not support a definitive assignment.
Recovery and achievable purity depend on the target concentration, resolution, load, sample stability, adsorption, solvent compatibility, and available material. Triclinic reviews these factors before defining a program; the page does not promise a fixed recovery, scale, or purity.
Related services
Pharmaceutical Impurity and Degradant Identification
Connect unknown peaks to process, stability, formulation, and degradation chemistry.
LC/MS and High-Resolution Mass Spectrometry
Obtain accurate-mass, isotope-pattern, and fragment evidence for soluble unknowns.
NMR Structure Elucidation
Resolve molecular connectivity and structural alternatives when enough purified material is available.
Root Cause Investigations
Relate an identified impurity or contaminant to process, material, packaging, or environmental sources.
Relevant white papers and technical resources
Reducing Late-Stage CMC Risk: Integrating High Resolution Mass Spectrometry and Micro Electron Diffraction for Rapid Definitive Impurity Identification
This paper addresses the small quantities often available for impurities detected in HPLC assays and shows how high-resolution mass spectrometry and MicroED can provide complementary formula and crystal-structure evidence. It is relevant when conventional collection and isolation cannot provide enough material for a traditional structure-elucidation workflow.
Download this White PaperIntegrating Microcrystal Electron Diffraction as a Mainstream Work Tool in Solid Form Development and Structure Elucidation
This paper explains how MicroED can determine structures from microcrystalline material and how complementary analytical evidence supports interpretation. It provides an alternative route when an isolated impurity is crystalline but unsuitable for conventional single-crystal X-ray diffraction.
Download this White PaperCommon questions about preparative LC impurity isolation
When does an impurity need to be isolated?
Isolation is appropriate when coelution or mixture complexity prevents interpretation, when NMR or another confirmatory technique requires purified material, or when a purified fraction is needed for comparison or further study.
What information is needed to assess preparative LC feasibility?
Useful inputs include the analytical method and chromatogram, detection wavelength or mass-spectrometric data, sample concentration and available quantity, solvent and buffer composition, stability information, and the desired amount and purity.
Can Triclinic combine isolation with LC-MS and NMR?
Yes. A project can connect chromatographic review, fit-for-purpose isolation, purity assessment, LC-HRMS or MS/MS, and NMR when the sample and decision require those steps.
How much sample is required for impurity isolation?
The required amount depends on impurity concentration, chromatographic resolution, collection and concentration losses, stability, and the sensitivity of the downstream method. Triclinic reviews the actual sample and method data before proposing a quantity.
What purity is needed before NMR analysis?
There is no universal purity threshold. The acceptable purity depends on the structural question, impurity profile, concentration, spectral overlap, and NMR experiment. The isolation and NMR plans are therefore developed together.
Can fractions from multiple preparative LC runs be combined?
Fractions may be pooled when analytical checks show that they contain the same target and meet the agreed composition criteria. Stability and the risk of introducing new contaminants or degradants must also be considered.
How do you verify that the impurity remains stable during isolation?
The workflow can use time, temperature, light, solvent, pH, and analytical controls appropriate to the known risk. Pre- and post-isolation chromatographic or mass-spectrometric comparisons can help distinguish the target from products formed during handling.
Is preparative LC appropriate for every impurity?
No. Preparative LC is most useful for chromatographically separable, solution-compatible targets. Volatile compounds, insoluble particles, inorganic materials, highly unstable species, or poorly resolved mixtures may require another isolation or analytical strategy.
Discuss an impurity-isolation project
Share the chromatogram, analytical method, impurity level, available sample, known stability constraints, and the structural question the work must answer.